Ob/Gyn Other
mm/dd/yyyy
 | 10/12/2009 | Update on DVT and PE in OB Gyn/Ortho Patients |  | 08/04/2009 | Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future |  | 08/04/2009 | Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer? |  | 08/04/2009 | Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer |  | 07/23/2009 | Hypoactive Sexual Desire Disorder in Women: Implications for Family Practice |  | 07/08/2009 | Patient Scenarios for Everyday Practice: Managing Advanced HER2-Positive Breast Cancer Throughout the Disease Continuum |  | 07/08/2009 | Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 1 |  | 07/08/2009 | Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 2 |  | 05/19/2009 | Optimizing the Use of Chemotherapy as the Backbone of Breast Cancer Treatment: An Update of the Latest Evidence |  | 05/04/2009 | Improving Epilepsy Management Throughout the Disease Continuum |  | 04/06/2009 | Finding Ways to Prevent, Circumvent, or Overcome Cardiovascular Toxicity Associated With Modern Breast Cancer Therapies |  | 04/06/2009 | Putting the Cardiovascular Safety of Breast Cancer Therapies Into Perspective: Pleading the Case for a Balanced View |  | 04/06/2009 | Appropriate Risk Assessment, Management, and Follow-Up Ensure Optimal Cardiovascular Outcomes in Patients With Breast Cancer |  | 04/02/2009 | New Insights Into Efficacy, Safety, and Optimal Use of Endocrine Therapies in Breast Cancer |  | 04/02/2009 | Switching and Up-Front Approaches to Hormone Therapy in Early Breast Cancer: Have the Latest Data Confirmed the Best Time to Introduce an Aromatase Inhibitor? |  | 04/02/2009 | Do All Drugs With Beneficial Effect on Bone Health Also Prevent Breast Cancer Recurrence? |  | 04/02/2009 | Prognostic or Predictive Tools and Strategies for Overcoming Endocrine Resistance: Still Investigational or Ready for Prime Time? |  | 01/08/2009 | MR-Guided Focused Ultrasound Therapy |  | 10/03/2008 | Progress in Detecting and Managing HER2-Positive Breast Cancer: A Brief Clinical Update |  | 09/19/2008 | Evolving Role of Targeted Therapy in Early-Stage Breast Cancer: Highlights of Recent Clinical Data |  | 08/28/2008 | Overcoming Challenges in Advanced Breast Cancer: How to Optimally Use Available Therapies |  | 08/12/2008 | Reducing the Burden of Overactive Bladder: A Global Perspective |  | 08/12/2008 | Overactive Bladder Is Highly Prevalent, Burdensome, and Costly |  | 08/12/2008 | Guidelines Help Clinicians to Diagnose and Manage Patients With Overactive Bladder |  | 08/12/2008 | Effective Options Available to Treat Overactive Bladder |  | 08/08/2008 | Moving Towards More Tailored Use of Antiangiogenic Therapies in Breast Cancer: A Clinical Update |  | 06/16/2008 | Advances in the Use of NNRTI-Based Treatment in HIV: Optimizing Patient Management |  | 06/16/2008 | Optimizing Outcomes in Treatment-Naïve Patients With HIV: Update on Efficacy of NNRTIs |  | 06/16/2008 | Practical Considerations in Selecting NNRTIs for Treatment-Naïve Patients With HIV |  | 06/12/2008 | Vaginitis |
More webcasts/CME>>>
All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.
|
|